|
DLGAP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.63800000230196E-08 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.165640E-01 |
| Stage1-vs-Stage3 |
9.070000E-01 |
| Stage1-vs-Stage4 |
1.327440E-01 |
| Stage2-vs-Stage3 |
1.549410E-01 |
| Stage2-vs-Stage4 |
1.463680E-02 |
| Stage3-vs-Stage4 |
1.095160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.49659999948426E-07 |
| Normal-vs-Asian |
1.11022302462516E-16 |
| Caucasian-vs-AfricanAmerican |
5.868400E-01 |
| Caucasian-vs-Asian |
2.426200E-02 |
| AfricanAmerican-vs-Asian |
3.542600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.714800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
8.66670000210235E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.359000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.992200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.226100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.078420E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.574000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.798400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.525600E-01 |
| Classical-VS-Follicular |
1.35280675550575E-12 |
| Classical-VS-Other |
2.319800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
9.91099999847478E-08 |
| Tall-VS-Other |
2.774400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.547400E-01 |
| Follicular-VS-Normal |
3.10129999459008E-08 |
| Other-VS-Normal |
1.672340E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.6251444634463E-12 |
| N0-vs-N1 |
7.099800E-02 |
|
|
